iBio Inc (AMEX: IBIO) is 64.96% higher on its value in year-to-date trading and has touched a low of $1.02 and a high of $28.20 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The IBIO stock was last observed hovering at around $2.11 in the last trading session, with the day’s gains setting it 0.15%.
Currently trading at $2.26, the stock is 26.84% and 58.98% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.04 million and changing 7.11% at the moment leaves the stock -55.34% off its SMA200. IBIO registered -90.74% loss for a year compared to 6-month loss of -59.43%. The firm has a 50-day simple moving average (SMA 50) of $658.51 and a 200-day simple moving average (SMA200) of -$1.69.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 91.53% gain in the last 1 month and extending the period to 3 months gives it a 75.19%, and is -32.54% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.52% over the week and 13.72% over the month.
iBio Inc (IBIO) has around 26 employees, a market worth around $19.26M and $0.05M in sales. Profit margin for the company is -54568.00%. Distance from 52-week low is 121.26% and -91.99% from its 52-week high. The company has generated returns on investments over the last 12 months (-221.57%).
iBio Inc quarterly earnings per share for the current quarter are estimated at $0.
iBio Inc (IBIO) Top Institutional Holders
24 institutions hold shares in iBio Inc (IBIO), with institutional investors hold 7.25% of the company’s shares. The shares outstanding are 8.52M, and float is at 8.48M with Short Float at 0.70%. Institutions hold 7.22% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 0.51 million shares valued at $0.31 million. The investor’s holdings represent 1.86% of the IBIO Shares outstanding. As of Jun 29, 2023, the second largest holder is Avantax Planning Partners, Inc. with 0.15 million shares valued at $94550.0 to account for 0.56% of the shares outstanding. The other top investors are Blackrock Inc. which holds 0.14 million shares representing 0.50% and valued at over $84140.0, while Bank Of New York Mellon Corporation holds 0.32% of the shares totaling 87474.0 with a market value of $53359.0.
iBio Inc (IBIO) Insider Activity
The most recent transaction is an insider sale by Brenner Martin. SEC filings show that Brenner Martin sold 4,881 shares of the company’s common stock on Nov 01 ’23 at a price of $0.27 per share for a total of $1296.0. Following the sale, the insider now owns 0.18 million shares.
iBio Inc disclosed in a document filed with the SEC on Oct 03 ’23 that Brenner Martinsold a total of 5,267 shares of the company’s common stock. The trade occurred on Oct 03 ’23 and was made at $0.30 per share for $1592.0. Following the transaction, the insider now directly holds 0.19 million shares of the IBIO stock.
Still, SEC filings show that on Oct 02 ’23, Brenner Martin () disposed off 4,215 shares at an average price of $0.31 for $1311.0. The insider now directly holds 192,650 shares of iBio Inc (IBIO).
